Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study
Lukas Schaffarczyk, Patricia Carla Mayer, Axel Hamprecht, Philipp Thelen · 2026
Read Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study by Lukas Schaffarczyk, Patricia Carla Mayer, Axel Hamprecht, Philipp Thelen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13476277.txt.
Description
Lukas Schaffarczyk and co-authors test rapid antibiotic susceptibility testing in bloodstream infections in a 2026 study. Knowing quickly which antibiotics work lets doctors stop broad first-guess therapy sooner. The hospital adopted the EUCAST rapid method, and the team compared four-month periods before and after adoption at one German center.
The study covered 126 patients with single-organism bloodstream infections from four bacterial species. After adoption, first-guess therapy lasted about forty hours instead of seventy-three. Rapid results arrived in about sixteen hours, far faster than the standard system, and agreement between methods was near perfect for most drugs. Some borderline results needed stand-in interpretation rules. The authors judge the rapid method practical for routine care.
Catalog record
| CREATOR | Lukas Schaffarczyk, Patricia Carla Mayer, Axel Hamprecht, Philipp Thelen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |